From GWAS to functional genomics-based precision medicine

DL Mattson, M Liang - Nature Reviews Nephrology, 2017 - nature.com
Several recent studies have provided insights into the genetic regulation of blood pressure.
A new study extends these findings by coupling genome-wide association study data with …

A bidirectional Mendelian randomization study supports causal effects of kidney function on blood pressure

Z Yu, J Coresh, G Qi, M Grams, E Boerwinkle… - Kidney international, 2020 - Elsevier
Blood pressure and kidney function have a bidirectional relation. Hypertension has long
been considered as a risk factor for kidney function decline. However, whether intensive …

Mendelian randomisation applied to drug development in cardiovascular disease: a review

LE Mokry, O Ahmad, V Forgetta… - Journal of medical …, 2015 - jmg.bmj.com
Despite increased expenditure, productivity of the pharmaceutical industry has decreased
and currently 90% of developed molecules entering phase II and phase III clinical trials fail …

Causal associations between blood pressure and the risk of myocardial infarction: A bidirectional Mendelian randomization study

ZQ Yang, TT Fan, Z Wang, WT Zhou… - Frontiers in …, 2022 - frontiersin.org
Introduction Many observational studies imply elevated blood pressure (BP) as a leading
risk factor for incident myocardial infarction (MI), but whether this relationship is causal …

Mendelian randomization studies on atherosclerotic cardiovascular disease: evidence and limitations

Q Hu, P Hao, Q Liu, M Dong, Y Gong, C Zhang… - Science China Life …, 2019 - Springer
Epidemiological research has revealed a galaxy of biomarkers, such as genes, molecules or
traits, which are associated with increased risk of atherosclerotic cardiovascular diseases …

Using Mendelian randomization studies to assess causality and identify new therapeutic targets in cardiovascular medicine

W Zhao, JJ Lee, A Rasheed, D Saleheen - Current genetic medicine …, 2016 - Springer
Integration of knowledge generated from genetic studies on intermediate biomarkers and
CHD can provide a reliable approach to help assess causal pathways in coronary heart …

Genetic risk factors and Mendelian randomization in cardiovascular disease

DI Swerdlow, AD Hingorani, SE Humphries - Current Cardiology Reports, 2015 - Springer
Cardiovascular disease encompasses several diverse pathological states that place a
heavy burden on individual and population health. The aetiological basis of many …

Genomics of hypertension: the road to precision medicine

S Padmanabhan, AF Dominiczak - Nature Reviews Cardiology, 2021 - nature.com
The known genetic architecture of blood pressure now comprises> 30 genes, with rare
variants resulting in monogenic forms of hypertension or hypotension and> 1,477 common …

Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk

HR Warren, E Evangelou, CP Cabrera, H Gao, M Ren… - Nature …, 2017 - nature.com
Elevated blood pressure is the leading heritable risk factor for cardiovascular disease
worldwide. We report genetic association of blood pressure (systolic, diastolic, pulse …

An academic clinician's road map to hypertension genomics: recent advances and future directions MMXX

EF Magavern, HR Warren, FL Ng, CP Cabrera… - …, 2021 - Am Heart Assoc
At the dawn of the new decade, it is judicious to reflect on the boom of knowledge about
polygenic risk for essential hypertension supplied by the wealth of genome-wide association …